Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered nucleic acid-targeting nucleic acids

Engineered nucleic acid-targeting nucleic acids

US Patent 11505808 · Granted Nov 22, 2022

Estimated economic value: $9,343,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid encoding reactions2024
CRISPR-associated (Cas) protein2024
CRISPR-associated (Cas) protein2024
Multi-primer amplification method for barcoding of target nucleic acids2023
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides2022
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides2022
Compositions and methods of nucleic acid-targeting nucleic acids2022
Compositions and methods of nucleic acid-targeting nucleic acids2022
CRISPR-associated (CAS) protein2022
CRISPR hybrid DNA/RNA polynucleotides and methods of use2022
Engineered nucleic-acid targeting nucleic acids2022
Engineered nucleic-acid targeting nucleic acids2022